75 related articles for article (PubMed ID: 12773163)
1. Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development.
Rennebeck G; Kleymenova EV; Anderson R; Yeung RS; Artzt K; Walker CL
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15629-34. PubMed ID: 9861021
[TBL] [Abstract][Full Text] [Related]
2. Complete inactivation of the TSC2 gene leads to formation of hamartomas.
Au KS; Hebert AA; Roach ES; Northrup H
Am J Hum Genet; 1999 Dec; 65(6):1790-5. PubMed ID: 10577937
[No Abstract] [Full Text] [Related]
3. Tuberous sclerosis associated with multiple hepatic lipomatous tumours.
Calleja-Stafrace D; Vella C
Images Paediatr Cardiol; 2016; 18(4):1-4. PubMed ID: 28405209
[No Abstract] [Full Text] [Related]
4. Reciprocal effects of mTOR inhibitors on pro-survival proteins dictate therapeutic responses in tuberous sclerosis complex.
McNamara MC; Hosios AM; Torrence ME; Zhao T; Fraser C; Wilkinson M; Kwiatkowski DJ; Henske EP; Wu CL; Sarosiek KA; Valvezan AJ; Manning BD
iScience; 2022 Nov; 25(11):105458. PubMed ID: 36388985
[TBL] [Abstract][Full Text] [Related]
5. A small molecule inhibitor of Rheb selectively targets mTORC1 signaling.
Mahoney SJ; Narayan S; Molz L; Berstler LA; Kang SA; Vlasuk GP; Saiah E
Nat Commun; 2018 Feb; 9(1):548. PubMed ID: 29416044
[TBL] [Abstract][Full Text] [Related]
6. Loss of Tuberous Sclerosis Complex 2 (TSC2) as a Predictive Biomarker of Response to mTOR Inhibitor Treatment in Patients with Hepatocellular Carcinoma.
Cho J; Lee J; Kim J; Kim ST; Lee S; Kim SY; Ha SY; Park CK; Lim HY
Transl Oncol; 2016 Oct; 9(5):466-471. PubMed ID: 27751352
[TBL] [Abstract][Full Text] [Related]
7. Evidence that TSC2 acts as a transcription factor and binds to and represses the promoter of Epiregulin.
Pradhan SA; Rather MI; Tiwari A; Bhat VK; Kumar A
Nucleic Acids Res; 2014 Jun; 42(10):6243-55. PubMed ID: 24748662
[TBL] [Abstract][Full Text] [Related]
8. Tuberous-sclerosis complex-related cell signaling in the pathogenesis of lung cancer.
Fuchs A; König K; Heukamp LC; Fassunke J; Kirfel J; Huss S; Becker AJ; Büttner R; Majores M
Diagn Pathol; 2014 Mar; 9():48. PubMed ID: 24593867
[TBL] [Abstract][Full Text] [Related]
9. Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer.
Tanwar PS; Mohapatra G; Chiang S; Engler DA; Zhang L; Kaneko-Tarui T; Ohguchi Y; Birrer MJ; Teixeira JM
Carcinogenesis; 2014 Mar; 35(3):546-53. PubMed ID: 24170201
[TBL] [Abstract][Full Text] [Related]
10. eIF4F suppression in breast cancer affects maintenance and progression.
Nasr Z; Robert F; Porco JA; Muller WJ; Pelletier J
Oncogene; 2013 Feb; 32(7):861-71. PubMed ID: 22484424
[TBL] [Abstract][Full Text] [Related]
11. Consequences of interrupted Rheb-to-AMPK feedback signaling in tuberous sclerosis complex and cancer.
Lacher MD; Pincheira RJ; Castro AF
Small GTPases; 2011 Jul; 2(4):211-216. PubMed ID: 22145093
[TBL] [Abstract][Full Text] [Related]
12. Gastric Adenocarcinoma in Association with Tuberous Sclerosis: Case report.
Ahmed S; Burney I; Sawhney S; Al-Moundhri MS
Sultan Qaboos Univ Med J; 2009 Apr; 9(1):75-8. PubMed ID: 21509279
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression.
McConkey DJ; Lee S; Choi W; Tran M; Majewski T; Lee S; Siefker-Radtke A; Dinney C; Czerniak B
Urol Oncol; 2010; 28(4):429-40. PubMed ID: 20610280
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction molecules in gliomas of all grades.
Ermoian RP; Kaprealian T; Lamborn KR; Yang X; Jelluma N; Arvold ND; Zeidman R; Berger MS; Stokoe D; Haas-Kogan DA
J Neurooncol; 2009 Jan; 91(1):19-26. PubMed ID: 18759130
[TBL] [Abstract][Full Text] [Related]
15. In silico regulatory analysis for exploring human disease progression.
Holloway DT; Kon M; DeLisi C
Biol Direct; 2008 Jun; 3():24. PubMed ID: 18564415
[TBL] [Abstract][Full Text] [Related]
16. Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.
Chakraborty S; Mohiyuddin SM; Gopinath KS; Kumar A
BMC Cancer; 2008 Jun; 8():163. PubMed ID: 18538015
[TBL] [Abstract][Full Text] [Related]
17. Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours.
Knowles MA; Hornigold N; Pitt E
Biochem Soc Trans; 2003 Jun; 31(Pt 3):597-602. PubMed ID: 12773163
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis.
Jones AC; Daniells CE; Snell RG; Tachataki M; Idziaszczyk SA; Krawczak M; Sampson JR; Cheadle JP
Hum Mol Genet; 1997 Nov; 6(12):2155-61. PubMed ID: 9328481
[TBL] [Abstract][Full Text] [Related]
19. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.
van Slegtenhorst M; de Hoogt R; Hermans C; Nellist M; Janssen B; Verhoef S; Lindhout D; van den Ouweland A; Halley D; Young J; Burley M; Jeremiah S; Woodward K; Nahmias J; Fox M; Ekong R; Osborne J; Wolfe J; Povey S; Snell RG; Cheadle JP; Jones AC; Tachataki M; Ravine D; Sampson JR; Reeve MP; Richardson P; Wilmer F; Munro C; Hawkins TL; Sepp T; Ali JB; Ward S; Green AJ; Yates JR; Kwiatkowska J; Henske EP; Short MP; Haines JH; Jozwiak S; Kwiatkowski DJ
Science; 1997 Aug; 277(5327):805-8. PubMed ID: 9242607
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
